Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Data Collection × Lymphoid × Clear all

Status

Recruiting 2 Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 6 Thoracic 4 NET 4 Endocrine 4 Other solid neoplasm 2 Other hematologic neoplasm 2 Genitourinary 2 Classical hematology 2 Tumor-Agnostic 1 Sarcoma 1 Plasma cell 1 Myeloid 1 Lymphoid 1 Head & Neck 1 Gastrointestinal 1 Dermatologic 1 Breast 1

Conditions

Lymphoma, Non-Hodgkin 1

Interventions

Rituximab 579 Cyclophosphamide 532 Vincristine 292 Doxorubicin 259 Etoposide 258 Cytarabine 220 Filgrastim 213 Prednisone 205 Methotrexate 190 fludarabine phosphate 183 Dexamethasone 174 fludarabine 149 Radiotherapy 139 Peripheral Blood Stem Cell Transplantation 131 Lenalidomide 119 Granulocyte Colony-Stimulating Factor 117 Bendamustine Hydrochloride 110 Melphalan 103 Bortezomib 99 ibrutinib 92 Busulfan 91 Whole-Body Irradiation 87 Mycophenolic Acid 84 Cyclosporine 70 Tacrolimus 68 Ifosfamide 68 Alemtuzumab 67 Gemcitabine 66 Leucovorin 65 Mercaptopurine 64

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05583318 2025-07-23

LymphoVie 2

Centre Hospitalier Universitaire Dijon

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡